Avid Bioservices, Inc. (CDMO) Cash flow
Market cap
$798.9M
P/E ratio
| 2012/04 | 2013/04 | 2014/04 | 2015/04 | 2016/04 | 2017/04 | 2018/04 | 2019/04 | 2020/04 | 2021/04 | 2022/04 | 2023/04 | 2024/04 | |
| Depreciation & amortization | 908,000 | 1 | 986,000 | 1 | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 7 | 11 |
| Stock-based compensation | 3 | 3 | 6 | 7 | 5 | 3 | 2 | 2 | 2 | 4 | 7 | 11 | 10 |
| Cash from operations | -35,878,000 | -20,926,000 | -28,254,000 | -36,019,000 | -39,591,000 | -39,786,000 | -26,766,000 | -12 | 6 | 31 | 9 | -13 | 11 |
| Capital expenditures | - | - | -755,000 | -9,047,000 | -9,324,000 | -1,501,000 | -3,019,000 | -2 | -4 | -10 | -56 | -78 | -32 |
| Cash from investing | -1,171,000 | -751,000 | -2,522,000 | -8,449,000 | -8,791,000 | -2,992,000 | -19,000 | 5 | -4 | -10 | -56 | -78 | -32 |
| Cash from financing | 32 | 39 | 73 | 35 | 42 | 28 | 22 | -3 | 1 | 112 | 3 | 3 | 20 |
| Free cash flow | - | - | |||||||||||
| FCF margin (%) | - | - |